AGL 24.40 Increased By ▲ 0.15 (0.62%)
AIRLINK 89.45 Decreased By ▼ -1.65 (-1.81%)
BOP 5.67 Increased By ▲ 0.09 (1.61%)
CNERGY 3.95 Decreased By ▼ -0.05 (-1.25%)
DCL 8.70 Decreased By ▼ -0.22 (-2.47%)
DFML 42.09 Decreased By ▼ -0.21 (-0.5%)
DGKC 89.35 Decreased By ▼ -1.45 (-1.6%)
FCCL 22.44 Decreased By ▼ -0.41 (-1.79%)
FFBL 36.35 Decreased By ▼ -0.45 (-1.22%)
FFL 9.29 Decreased By ▼ -0.11 (-1.17%)
HUBC 163.70 Decreased By ▼ -1.10 (-0.67%)
HUMNL 10.80 Increased By ▲ 0.18 (1.69%)
KEL 4.77 Increased By ▲ 0.05 (1.06%)
KOSM 4.12 Decreased By ▼ -0.02 (-0.48%)
MLCF 37.50 Decreased By ▼ -0.49 (-1.29%)
NBP 46.92 Increased By ▲ 3.67 (8.49%)
OGDC 132.90 Decreased By ▼ -2.44 (-1.8%)
PAEL 26.15 Decreased By ▼ -0.30 (-1.13%)
PIBTL 6.20 Increased By ▲ 0.07 (1.14%)
PPL 122.20 Decreased By ▼ -1.00 (-0.81%)
PRL 24.35 Increased By ▲ 0.14 (0.58%)
PTC 12.47 Increased By ▲ 0.05 (0.4%)
SEARL 58.10 Decreased By ▼ -1.10 (-1.86%)
TELE 7.92 Decreased By ▼ -0.11 (-1.37%)
TOMCL 35.70 Decreased By ▼ -0.45 (-1.24%)
TPLP 8.95 Decreased By ▼ -0.13 (-1.43%)
TREET 15.90 Decreased By ▼ -0.28 (-1.73%)
TRG 60.90 Decreased By ▼ -0.20 (-0.33%)
UNITY 31.50 Decreased By ▼ -0.25 (-0.79%)
WTL 1.26 Decreased By ▼ -0.03 (-2.33%)
BR100 8,496 Decreased By -0.5 (-0.01%)
BR30 27,202 Decreased By -87.8 (-0.32%)
KSE100 80,213 Decreased By -70 (-0.09%)
KSE30 25,712 Decreased By -80 (-0.31%)

The new chief executive of Merck & Co Inc on Friday gave Wall Street its first taste of his plan to revive the company, including exploring expansion into medical devices and diagnostics, according to an analyst.
Merck CEO Richard Clark laid out his vision for the company in a meeting with sell-side analysts, according to a note from J.P. Morgan analyst Chris Shibutani.
"Longer-term, we heard for the first time of the potential for how Merck could even envision itself as a company with businesses beyond pure pharma (pharmaceuticals), to include devices (implantable) and diagnostics as well," Shibutani said.

Copyright Reuters, 2005

Comments

Comments are closed.